Trevor Crosse > Marks & Clerk > London, England > Lawyer Profile
Marks & Clerk Offices
15 Fetter Lane
LONDON
EC4A 1BW
England
- Firm Profile
- Go to...
Trevor Crosse
Work Department
Intellectual Property
Position
Trevor is an intellectual property lawyer who advises clients on the commercialisation and enforcement of their IP rights, with a particular focus on patent and licensing disputes in the biotechnology and pharmaceutical sectors. His primary expertise lies in biopharmaceutical patent and SPC litigation, in which he regularly advises clients in relation to complex technical disputes.
Trevor has advised clients on actions in the High Court, Court of Appeal and Intellectual Property Enterprise Court, as well as in relation to references to the Court of Justice of the European Union. His work routinely involves multi-jurisdictional disputes and he has significant experience co-ordinating global litigation strategies for his clients.
Trevor has been recognised as a rising star by Managing Intellectual Property, IP Stars, 2018.
Example Cases
Eli Lilly v Genentech (Anti-IL17A/F antibodies)
Chugai Pharmaceutical Co v UCB Pharma (Antibody humanisation protocols)
Fujifilm Kyowa Kirin Biologics v AbbVie (Humira therapy for Crohn’s disease)
Fujifilm Kyowa Kirin Biologics v AbbVie (Humira dosing regimen)
Hospira UK v Genentech (Herceptin combination therapy)
Hospira UK v Genentech (Herceptin formulation)
Hospira UK v Genentech (Herceptin dosing regimen)
Regeneron Pharmaceuticals v Genentech (VEGF antagonists)
MedImmune v Novartis (Phage display)
Career
Trevor qualified as a solicitor in 2009 and joined Marks & Clerk Law in 2010. He became a partner of the firm in 2019.
Education
Postgraduate Diploma in Intellectual Property Law and Practice, Oxford University (2012)
Qualified as a Solicitor in England & Wales (2009)
Legal Practice Course, College of Law, Birmingham (2006)
Graduate Diploma in Law, College of Law, Birmingham (2005)
BSc Microbiology with Immunology, University of Leeds (2003)
Lawyer Rankings
London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
A team noted for its deep sector expertise, Osborne Clarke LLP
’s practice has recently been involved in mandates involving FRAND and SEP litigation. Experienced litigation specialist Arty Rajendra leads the department, while Tim Harris is noted for his expertise in the life sciences, pharma and biotech sectors. Will James bolsters the practice with his capabilities in handling litigation for large tech-driven companies, notably in the life sciences, electronics and medical devices fields. Trevor Crosse joined from Marks & Clerk in October 2022.
London > Industry focus > Life sciences and healthcare
Osborne Clarke LLP acts for a varied client roster, notably including BioNTech, Turbine, and Advent Life Sciences. Practice co-head Will James is a patent litigator who regularly acts for biotech, electronics, and medical device companies in disputes; while co-head Matthew Edwards maintains a corporate-focused practice, and advises companies and investors on M&A and venture capital investments. Marcus Vass primarily advises digital health companies on outsourcings and privacy matters. Peter Rudd-Clarke has broad experience in defending product liability claims and handling regulatory compliance issues. Having joined the team from Marks & Clerk in October 2022, Trevor Crosse has deep knowledge of SPC disputes and exclusivity rights.